← Back to news
🔴 BreakingNewsFDA

FDA Approves OJJAARA

WHY IT MATTERS

This approval may provide new treatment options for patients.

OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) received FDA approval.

View on FDA →
Read the original at FDA ↗
FDA ApprovalDrugTreatment

Related conditions

Acquired secondary polycythemiaAutosomal recessive non-syndromic intellectual disabilityOBSOLETE: Inherited predisposition to essential thrombocythemiaPrimary myelofibrosis

Related news

FDA
FDA Approves XTORO
XTORO (FINAFLOXACIN) received FDA approval.…
FDA
FDA Approves IOPIDINE
IOPIDINE (APRACLONIDINE HYDROCHLORIDE) received FDA approval.…
FDA
FDA Approves SABRIL
SABRIL (VIGABATRIN) received FDA approval.…
FDA
FDA Approves IOPIDINE
IOPIDINE (APRACLONIDINE HYDROCHLORIDE) received FDA approval.…